Senseonics Holdings, Inc. (SENS)
USD 0.78
(5.32%)
USD 0.78
(5.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 138.22 Million USD | -22.21% |
| 2022 | 177.67 Million USD | -10.68% |
| 2021 | 198.92 Million USD | 453.84% |
| 2020 | 35.91 Million USD | -72.91% |
| 2019 | 132.59 Million USD | -17.11% |
| 2018 | 159.97 Million USD | 248.19% |
| 2017 | 45.94 Million USD | 106.3% |
| 2016 | 22.27 Million USD | 305.52% |
| 2015 | 5.49 Million USD | -72.53% |
| 2014 | 19.99 Million USD | 199850.0% |
| 2013 | 10 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 154.06 Million USD | 0.46% |
| 2023 Q4 | 111.56 Million USD | -11.82% |
| 2023 Q3 | 126.51 Million USD | -8.47% |
| 2023 FY | 138.22 Million USD | -22.21% |
| 2023 Q2 | 138.22 Million USD | -10.28% |
| 2022 Q1 | 182.67 Million USD | 4.19% |
| 2022 Q2 | 177.67 Million USD | -2.74% |
| 2022 Q3 | 158.53 Million USD | -10.77% |
| 2022 Q4 | 153.36 Million USD | -3.26% |
| 2022 FY | 177.67 Million USD | -10.68% |
| 2021 Q3 | 188.09 Million USD | -5.44% |
| 2021 FY | 198.92 Million USD | 453.84% |
| 2021 Q1 | 219.62 Million USD | -6.59% |
| 2021 Q2 | 198.92 Million USD | -9.42% |
| 2021 Q4 | 175.32 Million USD | -6.79% |
| 2020 Q1 | 44.06 Million USD | 7.9% |
| 2020 Q3 | 195.94 Million USD | 445.54% |
| 2020 Q4 | 235.12 Million USD | 19.99% |
| 2020 FY | 35.91 Million USD | -72.91% |
| 2020 Q2 | 35.91 Million USD | -18.48% |
| 2019 Q3 | 35.26 Million USD | -73.4% |
| 2019 Q2 | 132.59 Million USD | -20.62% |
| 2019 Q1 | 167.04 Million USD | 69.77% |
| 2019 Q4 | 40.83 Million USD | 15.79% |
| 2019 FY | 132.59 Million USD | -17.11% |
| 2018 Q2 | 159.97 Million USD | -12.74% |
| 2018 Q4 | 98.39 Million USD | -23.96% |
| 2018 Q3 | 129.4 Million USD | -19.11% |
| 2018 FY | 159.97 Million USD | 248.19% |
| 2018 Q1 | 183.33 Million USD | -12.14% |
| 2017 Q1 | 60.13 Million USD | 27.53% |
| 2017 FY | 45.94 Million USD | 106.3% |
| 2017 Q4 | 208.66 Million USD | 168.14% |
| 2017 Q3 | 77.82 Million USD | 69.38% |
| 2017 Q2 | 45.94 Million USD | -23.6% |
| 2016 Q1 | 28.01 Million USD | -27.58% |
| 2016 FY | 22.27 Million USD | 305.52% |
| 2016 Q4 | 47.15 Million USD | 190.6% |
| 2016 Q3 | 16.22 Million USD | -27.14% |
| 2016 Q2 | 22.27 Million USD | -20.5% |
| 2015 Q1 | 1807.00 USD | 81.43% |
| 2015 Q4 | 38.68 Million USD | -1.51% |
| 2015 Q3 | 39.27 Million USD | 624.25% |
| 2015 Q2 | 5.42 Million USD | 300010.68% |
| 2015 FY | 5.49 Million USD | -72.53% |
| 2014 Q1 | 4419.00 USD | 0.0% |
| 2014 Q3 | 14.72 Thousand USD | -14.31% |
| 2014 Q4 | 996.00 USD | -93.24% |
| 2014 FY | 19.99 Million USD | 199850.0% |
| 2014 Q2 | 17.18 Thousand USD | 288.96% |
| 2013 FY | 10 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | 58.09 Million USD | -137.937% |
| Electromed, Inc. | 52.88 Million USD | -161.36% |
| Catheter Precision, Inc. | 30.73 Million USD | -349.701% |
| Xtant Medical Holdings, Inc. | 92.61 Million USD | -49.246% |